Skip to main content
Clinical Trials/NCT00909454
NCT00909454CompletedNot Applicable

V.I.P. Feasibility Study (Vitamin D Intake Project)

Augusta University2 sites in 1 country45 target enrollmentStarted: February 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
45
Locations
2
Primary Endpoint
Plasma 25-OH D level

Study Overview

Brief Summary

The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.

Detailed Description

To determine the feasibility of African American teenagers taking a daily vitamin D supplement over a 4 month period in terms of compliance and practical implementation.

To determine the differences in response in blood 25-OH D level between those randomly assigned to taking a 400 IU supplement versus 2000 IU per day and to determine if there are differences in blood 25-OH D level response depending on subject gender and overweight/obese versus healthy-weight status.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Single (Investigator)

Eligibility Criteria

Ages
14 Years to 19 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy African American Adolescents

Exclusion Criteria

  • Hypertension
  • Pregnancy
  • Medications that affect study outcome measures
  • Use of other vitamin and/or mineral supplement or herbal supplements
  • Individuals of other races

Outcomes

Primary Outcomes

Plasma 25-OH D level

Time Frame: 3-4 months from baseline to post-testing

Secondary Outcomes

  • Blood pressure(3-4 months from baseline to post-testing)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yanbin Dong

Professor

Augusta University

Study Sites (2)

Loading locations...

Similar Trials